Health-related quality of life and metabolic risk in patients with psychosis

Schizophrenia Research

Volumn 152, Issue 1, 2014, Pages 295-299

  Foldemo, Anniqa ^a,d   Wärdig, Rikard ^a   Bachrach Lindström, Margareta ^a   Edman, Gunnar ^b   Holmberg, Tommy ^c   Lindström, Torbjörn ^a,d   Valter, Lars ^c   Ösby, Urban ^b,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Department of Psychiatry ^*  (Sweden)

^d Department of Clinical Immunology and Transfusion Medicine   (Sweden)

Author keywords

Health related quality of life; Metabolic syndrome; Reference group; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC RISK; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; PUBLIC HEALTH; QUALITY OF LIFE; QUESTIONNAIRE; RISK; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SWEDEN; VERY ELDERLY; BIPOLAR DISORDER; BODY MASS; CHOLESTEROL BLOOD LEVEL; DELUSIONAL DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; ELEVATED BLOOD PRESSURE; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION RISK; RISK ASSESSMENT; SEX DIFFERENCE;

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

HEALTH-RELATED QUALITY OF LIFE; METABOLIC SYNDROME; REFERENCE GROUP; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC DISEASES; MIDDLE AGED; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84891631666     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.11.029     Document Type: Article

References (42)

1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645. http://dx.doi.org/110.1161/CIRCULATIONAHA.109.192644 (Epub 2009 Oct 5. PMID: 19805654, Oct 20).
2. American Psychiatric Association (DSM-IV) 1994, American Psychiatric Press, Washington D.C.
3. Bobes J., Garcia-Portilla P., Saiz P.A., Bascaran T., Bousono M. Quality of life measures in schizophrenia. Eur. Psychiatry 2005, 20(Suppl. 3):S313-S317.
4. Bobes J., Arango C., Garcia-Garcia M., Rejas J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr. Res. 2010, 119(1-3):101-109.
5. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37(1):53-72.
6. Burstrom K., Johannesson M., Diderichsen F. Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy 2001, 55(1):51-69.
7. Caron J., Lecomte Y., Stip E., Renaud S. Predictors of quality of life in schizophrenia. Community Ment. Health J. 2005, 41(4):399-417.
8. Carpiniello B., Pinna F., Tusconi M., Zaccheddu E., Fatteri F. Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study. Schizophr. Res. Treat. 2012, 2012:576369.
9. Cramer J.A., Rosenheck R., Xu W., Thomas J., Henderson W., Charney D.S. Quality of life in schizophrenia: a comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Schizophr. Bull. 2000, 26(3):659-666.
10. Cruce G., Ojehagen A. Risky use of alcohol, drugs and cigarettes in a psychosis unit: a 1 1/2year follow-up of stability and changes after initial screening. BMC Psychiatry 2007, 7:31.
11. Crump C., Winkleby M.A., Sundquist K., Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am. J. Psychiatry 2013, 170(3):324-333.
12. de Miguel Diez J., Esteban y Pena M.M., Puente Maestu L., Hernandez Barrera V., Carrasco Garrido P., Alvarez-Sala Walther L.A., Jimenez Garcia R. Relationship between tobacco consumption and health-related quality of life in adults living in a large metropolitan area. Lung 2010, 188(5):393-399.
13. Despres J.P., Arsenault B.J., Cote M., Cartier A., Lemieux I. Abdominal obesity: the cholesterol of the 21st century?. Can. J. Cardiol. 2008, 24(Suppl. D):7D-12D.
14. Dipasquale S., Pariante C.M., Dazzan P., Aguglia E., McGuire P., Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J. Psychiatr. Res. 2013, 47(2):197-207.
15. Dolan P. Modeling valuations for EuroQol health states. Med. Care 1997, 35(11):1095-1108.
16. Faulkner G., Cohn T., Remington G. Interventions to reduce weight gain in schizophrenia. Schizophr. Bull. 2007, 33(3):654-656.
17. Foley D.L., Morley K.I. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch. Gen. Psychiatry 2011, 68(6):609-616.
18. Fountoulakis K.N., Siamouli M., Panagiotidis P., Magiria S., Kantartzis S., Papastergiou N., Shoretsanitis G., Pantoula E., Moutou K., Kouidi E., Deres S. Obesity and smoking in patients with schizophrenia and normal controls: a case-control study. Psychiatry Res. 2010, 176(1):13-16.
19. Frisman G.H., Kristenson M. Psychosocial status and health related quality of life in relation to the metabolic syndrome in a Swedish middle-aged population. Eur. J. Cardiovasc. Nurs. 2009, 8(3):207-215.
20. Guy W., Cleary P., Bonato R.R. The chronic schizophrenic as a research subject: toxicity measures and their relationship to efficacy measures. Psychopharmacol. Bull. 1970, 6(4):34-58.
21. Heider D., Kitze K., Zieger M., Riedel-Heller S.G., Angermeyer M.C. Health-related quality of life in patients after lumbar disc surgery: a longitudinal observational study. Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehab. 2007, 16(9):1453-1460.
22. Hultsjo S. Mental healthcare staff's knowledge and experiences of diabetes care for persons with psychosis-a qualitative interview study. Prim. Health Care Res. Dev. 2012, 1-12.
23. Kind P., Dolan P., Gudex C., Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316(7133):736-741.
24. Klop B., Elte J.W., Cabezas M.C. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013, 5(4):1218-1240.
25. Konig H.H., Roick C., Angermeyer M.C. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. Eur. Psychiatry 2007, 22(3):177-187.
26. Laursen T.M., Munk-Olsen T., Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr. Opin. Psychiatry 2012, 25(2):83-88.
27. Marder S.R., Fenton W., Youens K. Schizophrenia, IX: cognition in schizophrenia - the MATRICS initiative. Am. J. Psychiatry 2004, 161(1):25.
28. McEvoy J.P., Zigman D., Margolese H.C. First- and second-generation antipsychotics. Can. J. Psychiatry 2010, 55(3):144-148. (discussion 148-149).
29. Mercier C., Peladeau N., Tempier R. Age, gender and quality of life. Community Ment. Health J. 1998, 34(5):487-500.
30. Meyer J.M., Stahl S.M. The metabolic syndrome and schizophrenia. Acta Psychiatr. Scand. 2009, 119(1):4-14.
31. Newcomer J.W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 19(Suppl. 1):1-93.
32. Renzaho A., Wooden M., Houng B. Associations between body mass index and health-related quality of life among Australian adults. Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehab. 2010, 19(4):515-520.
33. Resnick B., Orwig D., Wehren L., Hawkes W., Hebel R., Zimmerman S., Magaziner J. Health-related quality of life: is it a good indicator of function post THR?. Rehabil. Nurs. 2005, 30(2):46-54. (67).
34. Ritsner M., Modai I., Endicott J., Rivkin O., Nechamkin Y., Barak P., Goldin V., Ponizovsky A. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J. Clin. Psychiatry 2000, 61(11):880-889. (quiz 890).
35. Roohafza H., Sadeghi M., Talaei M., Pourmoghaddas Z., Sarrafzadegan N. Psychological status and quality of life in relation to the metabolic syndrome: Isfahan Cohort Study. Int. J. Endocrinol. 2012, 2012:380902.
36. Ruggeri M., Nose M., Bonetto C., Cristofalo D., Lasalvia A., Salvi G., Stefani B., Malchiodi F., Tansella M. Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br. J. Psychiatry J. Ment. Sci. 2005, 187:121-130.
37. Scott D., Happell B. The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues Ment. Health Nurs. 2011, 32(9):589-597.
38. Skantze K. Subjective quality of life and standard of living: a 10-year follow-up of out-patients with schizophrenia. Acta Psychiatr. Scand. 1998, 98(5):390-399.
39. Strassnig M., Brar J.S., Ganguli R. Body mass index and quality of life in community-dwelling patients with schizophrenia. Schizophr. Res. 2003, 62(1-2):73-76.
40. Strine T.W., Okoro C.A., Chapman D.P., Balluz L.S., Ford E.S., Ajani U.A., Mokdad A.H. Health-related quality of life and health risk behaviors among smokers. Am. J. Prev. Med. 2005, 28(2):182-187.
41. Trevisol D.J., Moreira L.B., Kerkhoff A., Fuchs S.C., Fuchs F.D. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J. Hypertens. 2011, 29(2):179-188.
42. Zygmuntowicz M., Owczarek A., Elibol A., Olszanecka-Glinianowicz M., Chudek J. Blood pressure for optimal health-related quality of life in hypertensive patients. J. Hypertens. 2013, 31(4):830-839.